ILOTYCIN Drug Patent Profile
When do Ilotycin patents expire, and when can generic versions of Ilotycin launch?
Ilotycin is a drug marketed by Dista and is included in three NDAs.
The generic ingredient in ILOTYCIN is erythromycin gluceptate. There are two drug master file entries for this compound. Additional details are available on the erythromycin gluceptate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ILOTYCIN?
- What are the global sales for ILOTYCIN?
- What is Average Wholesale Price for ILOTYCIN?
Summary for ILOTYCIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 118 |
| Patent Applications: | 3,788 |
| DailyMed Link: | ILOTYCIN at DailyMed |
US Patents and Regulatory Information for ILOTYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dista | ILOTYCIN | erythromycin | OINTMENT;OPHTHALMIC | 050368-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dista | ILOTYCIN GLUCEPTATE | erythromycin gluceptate | INJECTABLE;INJECTION | 050370-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dista | ILOTYCIN | erythromycin | TABLET, DELAYED RELEASE;ORAL | 061910-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dista | ILOTYCIN GLUCEPTATE | erythromycin gluceptate | INJECTABLE;INJECTION | 050370-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dista | ILOTYCIN GLUCEPTATE | erythromycin gluceptate | INJECTABLE;INJECTION | 050370-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
